L. Naldini
Molecular Biology · 2000–2015
A researcher in the Science corpus: 11 papers; trusts 3 researchers and is trusted by 15 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 93 citations into it; #3,242 of 17,773 by trust here, #2,259 by citations
- Genetics — 58 citations into it; #1,141 of 6,854 by trust here, #1,101 by citations
- Cancer Research — 20 citations into it
Whom L. Naldini trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts L. Naldini overall
Papers from L. Naldini's perspective
Ordered by how strongly the researchers L. Naldini trusts endorse each paper. Same corpus, a different order for every researcher.
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. (Journal of Clinical Investigation)
- Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 (Nature Medicine)
- LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 (Science)
- Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment (Nature Medicine)
- Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages (Science)
- Origins of circulating endothelial cells and endothelial outgrowth from blood. (Journal of Clinical Investigation)
- Gene therapy: twenty-first century medicine. (Annual Review of Biochemistry)
- Angiogenesis in cancer and other diseases (Nature)
- Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. (Cancer Cell)
- Tumour-educated macrophages promote tumour progression and metastasis (Nature Reviews. Cancer)
Their papers
- Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. (2005) — 1,359 citations
- Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells (2003) — 607 citations
- Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. (2011) — 633 citations
- Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences (2000) — 1,009 citations
- Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery (2007) — 916 citations
- Gene therapy returns to centre stage (2015) — 1,072 citations
- Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration (2006) — 737 citations
- Lentivirus-based Gene Therapy of Hematopoietic Stem Cells in Wiskott-Aldrich Syndrome (2013) — 965 citations
- Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy (2013) — 1,156 citations
- Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke (2009) — 467 citations
- Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics (2001) — 1,397 citations